The Female Health Company manufactures, markets and sells FC female condoms (FC1 and FC2), the only FDA approved products under a woman's control that provide dual protection against unintended pregnancy and sexually transmitted infections ("STI's"), including HIV/AIDS.
The Female Health Company is publicly traded on the NASDAQ-CM stock exchange under the symbol "FHCO".
FC Female Condoms (FC) have undergone extensive testing for efficacy, safety and acceptability in the United States and many countries around the world. Certain studies have shown that having FC available allows women and men to access more prevention options and results in an increase in protected sex acts and a decrease in STIs, including HIV/AIDS.
FC have high acceptability among both men and women in may countries. FC1 is currently sold or available through various channels in 116 countries. FC2 is currently available in 77 countries.